Sandu Pharmaceuticals fundamental analysis

SANDUPHQ

39

0.36 (0.93%)
Last updated on 24 Dec, 2025 | 15:16 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Sandu Pharmaceuticals Fundamentals

P/E Ratio

24.05

P/B Ratio

1.12

Div. Yield

2.07

Sector P/E

71.29

Sector P/B

1.09

Sec. Div. Yield

0.56

Sandu Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 24.05, compared to the sector average of 71.29. Its P/B Ratio stands at 1.12, while the sector’s is 1.09. In terms of returns, the stock offers a Dividend Yield of 2.07%, which is than the sector’s 0.56%.

Sandu Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Sandu Pharmaceuticals reflects: Price – Attractive, Growth – Moderate, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.